Taken together, these findings suggest the feedback inhibition on TRIM3 by IFN-β, as mentioned above, likely inhibits the suppressive effect of TRIM3 on NSCLC progression. This evidence concerns the gene IFNB1 and non-small cell lung carcinoma.